Blood cancer patients to benefit from first targeted treatment available on the NHS
Patients in England with a form of blood cancer known as marginal zone lymphoma (MZL) can now benefit from a take-at-home tablet available on the NHS. The game changing treatment could halt the progression of their cancer and provide an alternative to rounds of chemotherapy.
News